The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Paola Secchiero

Department of Morphology and Embryology

University of Ferrara

Via Fossato di Mortara 66

44100 Ferrara



Name/email consistency: high



  • Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy. 2001 - 2008


  1. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Secchiero, P., Zauli, G. Curr. Opin. Hematol. (2008) [Pubmed]
  2. Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Secchiero, P., Corallini, F., Rimondi, E., Chiaruttini, C., di Iasio, M.G., Rustighi, A., Del Sal, G., Zauli, G. Blood (2008) [Pubmed]
  3. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells. Secchiero, P., Melloni, E., Tiribelli, M., Gonelli, A., Zauli, G. J. Leukoc. Biol. (2008) [Pubmed]
  4. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70. Secchiero, P., di Iasio, M.G., Gonelli, A., Barbarotto, E., Melloni, E., Tiribelli, M., Chiaruttini, C., Zauli, G. J. Cell. Physiol. (2007) [Pubmed]
  5. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Secchiero, P., Zerbinati, C., di Iasio, M.G., Melloni, E., Tiribelli, M., Grill, V., Zauli, G. Curr. Drug Metab. (2007) [Pubmed]
  6. Antiangiogenic activity of the MDM2 antagonist nutlin-3. Secchiero, P., Corallini, F., Gonelli, A., Dell'Eva, R., Vitale, M., Capitani, S., Albini, A., Zauli, G. Circ. Res. (2007) [Pubmed]
  7. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero, P., Corallini, F., Barbarotto, E., Melloni, E., di Iasio, M.G., Tiribelli, M., Zauli, G. J. Cell. Physiol. (2006) [Pubmed]
  8. Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). Secchiero, P., Barbarotto, E., Tiribelli, M., Zerbinati, C., di Iasio, M.G., Gonelli, A., Cavazzini, F., Campioni, D., Fanin, R., Cuneo, A., Zauli, G. Blood (2006) [Pubmed]
  9. TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Secchiero, P., Corallini, F., di Iasio, M.G., Gonelli, A., Barbarotto, E., Zauli, G. Blood (2005) [Pubmed]
  10. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero, P., Tiribelli, M., Barbarotto, E., Celeghini, C., Michelutti, A., Masolini, P., Fanin, R., Zauli, G. J. Cell. Physiol. (2005) [Pubmed]
  11. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. Secchiero, P., Barbarotto, E., Gonelli, A., Tiribelli, M., Zerbinati, C., Celeghini, C., Agostinelli, C., Pileri, S.A., Zauli, G. Am. J. Pathol. (2005) [Pubmed]
  12. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A., Zauli, G. Blood (2004) [Pubmed]
  13. TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Secchiero, P., Zerbinati, C., Rimondi, E., Corallini, F., Milani, D., Grill, V., Forti, G., Capitani, S., Zauli, G. Cell. Mol. Life Sci. (2004) [Pubmed]
  14. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Secchiero, P., Gonelli, A., Carnevale, E., Milani, D., Pandolfi, A., Zella, D., Zauli, G. Circulation (2003) [Pubmed]
  15. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. Secchiero, P., Milani, D., Gonelli, A., Melloni, E., Campioni, D., Gibellini, D., Capitani, S., Zauli, G. J. Leukoc. Biol. (2003) [Pubmed]
  16. Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D., Zauli, G. Blood (2002) [Pubmed]
  17. Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Secchiero, P., Gonelli, A., Celeghini, C., Mirandola, P., Guidotti, L., Visani, G., Capitani, S., Zauli, G. Blood (2001) [Pubmed]
WikiGenes - Universities